UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2021	$ 37	$ 841	$ (9,054)	$ 115,314	$ 107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Common stock issued upon exercise of employee stock options	$ 0	19	0	0	19
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	43	0	0	43
Foreign currency translation adjustment	0	0	(506)	0	(506)
Common stock dividends	0	0	0	(1,060)	(1,060)
Net income	0	0	0	3,534	3,534
Equity Balance, value at Mar. 31, 2022	$ 37	903	(9,560)	117,789	109,168
Equity Balance, shares at Mar. 31, 2022	3,655
Equity Balance, value at Dec. 31, 2021	$ 37	841	(9,054)	115,314	107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Foreign currency translation adjustment					(2,804)
Net income					7,638
Equity Balance, value at Jun. 30, 2022	$ 36	0	(11,858)	119,293	107,471
Equity Balance, shares at Jun. 30, 2022	3,625
Equity Balance, value at Mar. 31, 2022	$ 37	903	(9,560)	117,789	109,168
Equity Balance, shares at Mar. 31, 2022	3,655
Common stock issued upon exercise of employee stock options	$ 0	4	0	0	4
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	40	0	0	40
Common stock purchased and retired	$ 0	(947)	0	(1,548)	(2,495)
Common stock purchased and retired, shares	(30)
Foreign currency translation adjustment	$ 0	0	(2,298)	0	(2,298)
Common stock dividends	0	0	0	(1,051)	(1,051)
Net income	0	0	0	4,103	4,103
Equity Balance, value at Jun. 30, 2022	$ 36	0	(11,858)	119,293	107,471
Equity Balance, shares at Jun. 30, 2022	3,625
Equity Balance, value at Dec. 31, 2022	$ 36	251	(12,039)	126,006	114,254
Equity Balance, shares at Dec. 31, 2022	3,628
Common stock issued upon exercise of employee stock options	$ 0	21	0	0	21
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	50	0	0	50
Foreign currency translation adjustment	0	0	549	0	549
Common stock dividends	0	0	0	(1,070)	(1,070)
Net income	0	0	0	4,214	4,214
Equity Balance, value at Mar. 31, 2023	$ 36	322	(11,491)	129,150	118,018
Equity Balance, shares at Mar. 31, 2023	3,628
Equity Balance, value at Dec. 31, 2022	$ 36	251	(12,039)	126,006	114,254
Equity Balance, shares at Dec. 31, 2022	3,628
Foreign currency translation adjustment					1,053
Net income					8,414
Equity Balance, value at Jun. 30, 2023	$ 36	432	(10,986)	132,279	121,761
Equity Balance, shares at Jun. 30, 2023	3,629
Equity Balance, value at Mar. 31, 2023	$ 36	322	(11,491)	129,150	118,018
Equity Balance, shares at Mar. 31, 2023	3,628
Common stock issued upon exercise of employee stock options	$ 0	60	0	0	60
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	50	0	0	50
Foreign currency translation adjustment	0	0	504	0	504
Common stock dividends	0	0	0	(1,071)	(1,071)
Net income	0	0	0	4,200	4,200
Equity Balance, value at Jun. 30, 2023	$ 36	$ 432	$ (10,986)	$ 132,279	$ 121,761
Equity Balance, shares at Jun. 30, 2023	3,629